Differential Impact of Heart Failure With Reduced Ejection Fraction on Men and Women

Journal of the American College of Cardiology

Volumn 73, Issue 1, 2019, Pages 29-40

  Dewan, Pooja ^a   Rørth, Rasmus ^a,b   Jhund, Pardeep S ^a   Shen, Li ^a   Raparelli, Valeria ^c,d   Petrie, Mark C ^a   Abraham, William T ^e   Desai, Akshay S ^f   Dickstein, Kenneth ^g   Køber, Lars ^b   Mogensen, Ulrik M ^a,b   Packer, Milton ^h   Rouleau, Jean L ⁱ   Solomon, Scott D ^f   Swedberg, Karl ^j,k   Zile, Michael R ^l   McMurray, John J V ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b Rigshospitalet   (Denmark)

^c MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

^e OHIO STATE UNIVERSITY   (United States)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

^g STAVANGER UNIVERSITY HOSPITAL   (Norway)

^h BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

ⁱ MONTREAL HEART INSTITUTE   (Canada)

^j UNIVERSITY OF GOTHENBURG   (Sweden)

^k NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^l MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

more..

Author keywords

heart failure; sex; women

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANTICOAGULANT AGENT; DIURETIC AGENT; ALISKIREN; AMIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; BRAIN NATRIURETIC PEPTIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FUMARIC ACID DERIVATIVE; PEPTIDE FRAGMENT; PRO-BRAIN NATRIURETIC PEPTIDE (1-76);

ADULT; AGE; AGED; ARTICLE; COMORBIDITY; DRUG UTILIZATION; FEMALE; FOOT EDEMA; GENDER; HEART FAILURE WITH REDUCED EJECTION FRACTION; HEART RATE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBESITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; QUESTIONNAIRE; SYSTOLIC BLOOD PRESSURE; BLOOD; COMPLICATION; CONTROLLED STUDY; FOLLOW UP; HEART FAILURE; HEART STROKE VOLUME; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; SEX FACTOR;

ADULT; AGED; AMIDES; ANGIOTENSIN RECEPTOR ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; FEMALE; FOLLOW-UP STUDIES; FUMARATES; HEART FAILURE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROGNOSIS; QUALITY OF LIFE; SEX FACTORS; STROKE VOLUME;

EID: 85059103599     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2018.09.081     Document Type: Article

References (35)

1. Shah, M.R., Granger, C.B., Bart, B.A., et al. Sex-related differences in the use and adverse effects of angiotensin-converting enzyme inhibitors in heart failure: the study of patients intolerant of converting enzyme inhibitors registry. Am J Med 109 (2000), 489–492.
2. Simon, T., Mary-Krause, M., Funck-Brentano, C., Jaillon, P., Sex differences in the prognosis of congestive heart failure results from the Cardiac Insufficiency Bisoprolol Study (CIBIS II). Circulation 103 (2001), 375–380.
3. Ghali, J.K., Piña, I.L., Gottlieb, S.S., Deedwania, P.C., Wikstrand, J.C., Metoprolol CR/XL in female patients with heart failure: analysis of the experience in Metoprolol Extended-Release Randomized Intervention Trial in Heart Failure (MERIT-HF). Circulation 105 (2002), 1585–1591.
4. Ghali, J.K., Krause-Steinrauf, H.J., Adams, K.F., et al. Gender differences in advanced heart failure: insights from the BEST study. J Am Coll Cardiol 42 (2003), 2128–2134.
5. Gustafsson, F., Torp-Pedersen, C., Burchardt, H., et al. Female sex is associated with a better long-term survival in patients hospitalized with congestive heart failure. Eur Heart J 25 (2004), 129–135.
6. Majahalme, S.K., Baruch, L., Aknay, N., et al. Comparison of treatment benefit and outcome in women versus men with chronic heart failure (from the Valsartan Heart Failure Trial). Am J Cardiol 95 (2005), 529–532.
7. O'Meara, E., Clayton, T., McEntegart, M.B., et al. Sex differences in clinical characteristics and prognosis in a broad spectrum of patients with heart failure: results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program. Circulation 115 (2007), 3111–3120.
8. Russo, A.M., Poole, J.E., Mark, D.B., et al. Primary prevention with defibrillator therapy in women: Results from the sudden cardiac death in heart failure trial. J Cardiovasc Electrophysiol 19 (2008), 720–724.
9. Rathore, S.S., Foody, J.M., Wang, Y., et al. Sex, quality of care, and outcomes of elderly patients hospitalized with heart failure: findings from the National Heart Failure Project. Am Heart J 149 (2005), 121–128.
10. Sheppard, R., Behlouli, H., Richard, H., Pilote, L., Effect of gender on treatment, resource utilization, and outcomes in congestive heart failure in Quebec, Canada. Am J Cardiol 95 (2005), 955–959.
11. Lenzen, M.J., Rosengren, A., Scholte op Reimer, W.J.M., et al. Management of patients with heart failure in clinical practice: differences between men and women. Heart, 94, 2008, e10.
12. Yancy, C.W., Fonarow, G.C., Albert, N.M., et al. Influence of patient age and sex on delivery of guideline-recommended heart failure care in the outpatient cardiology practice setting: Findings from IMPROVE HF. Am Heart J 157 (2009), 754–762.e2.
13. Linde, C., Ståhlberg, M., Benson, L., et al. Gender, underutilization of cardiac resynchronization therapy, and prognostic impact of QRS prolongation and left bundle branch block in heart failure. Europace 17 (2015), 424–431.
14. Ponikowski, P., Voors, A.A., Anker, S.D., et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 37 (2016), 2129–2200.
15. Yancy, C.W., Jessup, M., Bozkurt, B., et al. 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. J Am Coll Cardiol 70 (2017), 776–803.
16. McMurray, J.J.V., Packer, M., Desai, A.S., et al. Angiotensin–neprilysin inhibition versus enalapril in heart failure. N Engl J Med 371 (2014), 993–1004.
17. McMurray, J.J.V., Krum, H., Abraham, W.T., et al. Aliskiren, enalapril, or aliskiren and enalapril in heart failure. N Engl J Med 374 (2016), 1521–1532.
18. Green, C.P., Porter, C.B., Bresnahan, D.R., Spertus, J.A., Development and evaluation of the Kansas City cardiomyopathy questionnaire: a new health status measure for heart failure. J Am Coll Cardiol 35 (2000), 1245–1255.
19. Lewis, E.F., Lamas, G.A., O’ Meara, E., et al. Characterization of health-related quality of life in heart failure patients with preserved versus low ejection fraction in CHARM. Eur J Heart Fail 9 (2007), 83–91.
20. Kostis, J.B., Shelton, B., Gosselin, G., et al. Adverse effects of enalapril in the Studies of Left Ventricular Dysfunction (SOLVD). Am Heart J 131 (1996), 350–355.
21. Yesil, S., Yesil, M., Bayata, S., Postaci, N., ACE inhibitors and cough. Angiology 45 (1994), 805–808.
22. Rathore, S.S., Wang, Y., Krumholz, H.M., Sex-based differences in the effect of digoxin for the treatment of heart failure. N Engl J Med 347 (2002), 1403–1411.
23. Mast, M.S., Kadji, K.K., How female and male physicians’ communication is perceived differently. Patient Educ Couns 101 (2018), 1697–1701.
24. White, A.A., Some advice for physicians and other clinicians treating minorities, women, and other patients at risk of receiving health care disparities. J Racial Ethn Heal Disparities 4 (2017), 472–479.
25. MacRae, H., “It's my body, my future”: older women's views of their interactions with physicians. J Women Aging 28 (2016), 211–224.
26. Bertakis, K.D., The influence of gender on the doctor–patient interaction. Patient Educ Couns 76 (2009), 356–360.
27. Bittner, V., Cardiac rehabilitation for women. Adv Exp Med Biol 1065 (2018), 565–577.
28. Marzolini, S., Brooks, D., Oh, P.I., Sex differences in completion of a 12-month cardiac rehabilitation programme: an analysis of 5922 women and men. Eur J Prev Cardiol 15 (2008), 698–703.
29. Piña, I.L., Bittner, V., Clare, R.M., et al. Effects of exercise training on outcomes in women with heart failure: analysis of HF-ACTION (Heart Failure–A Controlled Trial Investigating Outcomes of Exercise TraiNing) by sex. J Am Coll Cardiol HF 2 (2014), 180–186.
30. Zusterzeel, R., Selzman, K.A., Sanders, W.E., et al. Cardiac resynchronization therapy in women: US food and drug administration meta-analysis of patient-level data. JAMA Intern Med 174 (2014), 1340–1348.
31. Ogilvie, I.M., Newton, N., Welner, S.A., Cowell, W., Lip, G.Y.H., Underuse of oral anticoagulants in atrial fibrillation: a systematic review. Am J Med 123 (2010), 638–645.
32. Gardner, J.D., Brower, G.L., Janicki, J.S., Gender differences in cardiac remodeling secondary to chronic volume overload. J Card Fail 8 (2002), 101–107.
33. Piro, M., Della Bona, R., Abbate, A., Biasucci, L.M., Crea, F., Sex-related differences in myocardial remodeling. J Am Coll Cardiol 55 (2010), 1057–1065.
34. Piña, I.L., Zheng, Q., She, L., et al. Sex difference in patients with ischemic heart failure undergoing surgical revascularization. Circulation 137 (2018), 771–780.
35. Steffel, J., Varma, N., Robertson, M., et al. Effect of gender on outcomes after cardiac resynchronization therapy in patients with a narrow QRS complex: a subgroup analysis of the EchoCRT trial. Circ Arrhythm Electrophysiol, 9, 2016, e003924.